Table 2 Non-lipid variables and lipid levels of the CHD-free subjects by the APOA5 rs662799 genotypes

 Age, years

59.44 ± 12.99

59.88 ± 12.95

63.60 ± 5.89

0.787

59.00 ± 10.86

59.29 ± 7.72

64.50 ± 7.77

0.737

 Weight, kg

64.00 ± 8.87

66.53 ± 9.73

69.00 ± 12.08

0.366

59.13 ± 10.76

59.46 ± 8.92

52.50 ± 3.53

0.635

 BMI, kg/m²

23.30 ± 3.11

23.68 ± 2.96

25.28 ± 4.67

0.483

23.93 ± 4.08

24.48 ± 3.26

20.88 ± 0.85

0.404

 Menopause, n (%)

NA

NA

NA

36 (85.71)

24 (85.71)

2 (100.00 %)

0.784

 Hypertension, n (%)

14 (32.56)

13 (39.39)

2 (40.00)

0.545

12 (28.57)

14 (50.00)

1 (50.00)

0.079

 Diabetes, n (%)

4 (9.30)

5 (15.15)

0 (0.00)

0.898

2 (4.76)

4 (14.29)

0 (0.00)

0.305

 TG, mmol/L

1.20 ± 0.68

1.24 ± 0.50

2.07 ± 1.06

0.060

1.33 ± 0.65

1.58 ± 0.74

1.15 ± 0.23

0.288

 TC, mmol/L

3.91 ± 1.08

3.77 ± 0.93

4.27 ± 0.68

0.554

4.30 ± 1.01

3.89 ± 1.05

3.51 ± 0.09

0.174

 LDL-C, mmol/L

2.73 ± 2.44

2.26 ± 0.75

2.73 ± 0.63

0.550

2.59 ± 0.76

2.26 ± 0.77

2.10 ± 0.00

0.161

 HDL-C, mmol/L

1.08 ± 0.35

0.98 ± 0.20

0.92 ± 0.25

0.264

1.18 ± 0.25

1.02 ± 0.24

0.92 ± 0.01

0.045

 ApoAI, g/L

1.10 ± 0.15

1.06 ± 0.17

1.08 ± 0.17

0.705

1.16 ± 0.16

1.09 ± 0.22

0.99 ± 0.16

0.152

 ApoB, g/L

0.71 ± 0.25

0.73 ± 0.24

0.85 ± 0.22

0.456

0.77 ± 0.25

0.73 ± 0.21

0.66 ± 0.10

0.680

 Lp(a), mg/L

251.09 ± 323.39

280.68 ± 327.62

272.26 ± 321.52

0.926

236.26 ± 248.07

260.84 ± 271.67

211.95 ± 17.32

0.911

 TG/HDL-C

1.29 ± 0.97

1.38 ± 0.78

2.62 ± 2.11

0.066

1.22 ± 0.78

1.63 ± 0.87

1.25 ± 0.25

0.131

 TC/HDL-C

3.86 ± 1.43

3.91 ± 0.96

4.85 ± 1.24

0.247

3.69 ± 0.73

3.85 ± 0.82

3.83 ± 0.07

0.693

 LDL-C/HDL-C

2.64 ± 1.92

2.36 ± 0.81

3.11 ± 0.92

0.506

2.23 ± 0.63

2.24 ± 0.69

2.29 ± 0.02

0.992

 ApoB/apoAI

0.66 ± 0.27

0.69 ± 0.22

0.81 ± 0.22

0.424

0.66 ± 0.19

0.67 ± 0.17

0.69 ± 0.21

0.951